CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

DAPTACEL

DAPTACELNeutral
AI Analysis

Summary

DAPTACEL is indicated for active immunization against diphtheria, tetanus and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age.

Importance:1/10
Sentiment:
0.00
vaccineimmunizationpediatric
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 27, 2026 7:44 PM

Read Original